Jeff Yass’s Ambit Biosciences Corp AMBI Stock Holding History

Jeff Yass’s Portfolio AMBI Stock Details AMBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-11,344	Closed	-$103K	–	10426
2014 Q1	$103K	Buy	+11,344	New	+$120K	﹤0.01%	8555

Other funds holding AMBI

Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jeff Yass's AMBI Position: Q2 2014 in Review

Jeff Yass sold out of Ambit Biosciences Corp (AMBI) in Q2 2014, closing a stake of 11,344 shares — an estimated $103K sold.

Jeff Yass first reported a position in AMBI in Q1 2014 and held it in 1 quarter. The position peaked at $103K in Q1 2014. 36 funds tracked by Wall St. Rank hold AMBI as of Q2 2014.

Jeff Yass reported no remaining Ambit Biosciences Corp position as of Q2 2014 after selling out during the quarter.
Jeff Yass sold 11,344 Ambit Biosciences Corp shares in Q2 2014, an estimated $103K.
Jeff Yass first reported a position in Ambit Biosciences Corp in Q1 2014 and held it in 1 quarter.
Jeff Yass's Ambit Biosciences Corp position peaked at $103K in Q1 2014.
36 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q2 2014.

Based on Susquehanna International Group's 13F filing for Q2 2014, filed 14 Aug 2014.